Plant Biotechnology Equipment Global Market Report 2025

The plant biotechnology equipment market size has grown strongly in recent years. It will grow from $15.43 billion in 2024 to $16.55 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period is driven by rising demand for high-yield crops, growing adoption of biotech and bioengineered crops, increasing use of plant-derived compounds in pharmaceuticals, and expanding demand for organic produce.

The plant biotechnology equipment market size is expected to see strong growth in the next few years. It will grow to $22.15 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth during the forecast period is driven by the increasing population driving food demand, rising emphasis on high-value ingredient production, growing research on stress-resistant crop varieties, increasing awareness of precision farming, and rising demand for biopesticides and biofertilizers. Primary trends in the forecast period include advancements in automation technologies, integration of robotics in plant handling, development of sensor-based monitoring systems, advancement in fermentation and cell culture systems, and integration of modular and scalable equipment designs.

The increase in climate change and the growing need for crop resilience are expected to enhance the growth of the plant biotechnology equipment market in the coming years. Climate change refers to long term shifts in temperature, precipitation patterns, and the rising frequency of extreme weather events, which place stress on traditional crop varieties. The demand for resilient crops is increasing due to these extreme events, which disrupt crop production and threaten food security. Plant biotechnology equipment helps address these challenges by providing advanced tools that support the development of stress tolerant crop varieties capable of withstanding harsh environmental conditions. For example, in February 2025, according to the United States Department of Agriculture, U.S. agriculture emitted approximately 663.6 million metric tons of carbon dioxide equivalent in 2022, underscoring the sector’s vulnerability to climate change. Therefore, the challenges caused by climate change and the growing need for resilient crops are enhancing the growth of the plant biotechnology equipment market.

Leading companies operating in the plant biotechnology equipment market are emphasizing the development of advanced cell culture systems and cultivation-free bioprocessing platforms, such as plant cell suspension culture with molecular fingerprint replication, to achieve consistent and scalable production of high-value plant-derived compounds. Plant cell suspension culture with molecular fingerprint replication is a precise cultivation method in which plant cells are grown in liquid media to produce compounds that accurately mirror the molecular characteristics of the original plant. For instance, in March 2025, PHC Corporation of North America, a US-based laboratory equipment provider, introduced the PHCbi MCO-171AICUVD-PA high-heat CO₂ incubator. This system incorporates an antimicrobial inCu-saFe interior that combines copper’s germicidal effects with stainless steel durability, a Safe Cell UV-LED germicidal bulb, and an optional 11-hour high-heat sterilization cycle for complete decontamination. Through these advanced incubation technologies, PHC enhances controlled plant cell culture applications, emphasizing sterility, precision, and reliability in modern plant biotechnology processes.

In May 2025, Brookfield Corporation, a Canada-based investment management company, and Quebec Deposit and Investment Fund, a Canada-based pension fund, acquired Antylia Scientific for $1.34 billion. Through this acquisition, they aim to strengthen Antylia Scientific’s growth in the life sciences sector by enhancing its commercial strategy and procurement processes. Antylia Scientific is a US-based instrumentation company offering a comprehensive range of laboratory equipment for plant biotechnology applications.

Major players operating in the plant biotechnology equipment market are Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN N.V., PerkinElmer, Inc., Waters Corporation, Sartorius Aktiengesellschaft, Bruker Corporation, Eppendorf AG, Oxford Nanopore Technologies plc, Hamilton Company, Shimadzu Corporation, Corning Incorporated, LGC Limited, Promega Corporation, Analytik Jena GmbH+Co. KG, Photon Systems Instruments, Labconco Corporation, Memmert GmbH, Esco Lifesciences Group Ltd., Qubit Systems Inc., Geneq, Inc., LemnaTec GmbH.

North America was the largest region in the plant biotechnology equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plant biotechnology equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The plant biotechnology equipment market research report is one of a series of new reports that provides plant biotechnology equipment market statistics, including plant biotechnology equipment industry global market size, regional shares, competitors with a plant biotechnology equipment market share, detailed plant biotechnology equipment market segments, market trends and opportunities, and any further data you may need to thrive in the plant biotechnology equipment industry. This plant biotechnology equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Plant biotechnology equipment consists of specialized instruments and tools used in the research, development, and production of plants through biotechnological methods. These include tissue culture systems, bioreactors, gene-editing tools, and analytical devices that support plant propagation, genetic modification, and disease-resistance studies. Such equipment enables precise manipulation, monitoring, and analysis of plant cells, tissues, and genes to improve crop traits, boost productivity, and develop sustainable agricultural solutions.

The major equipment types in plant biotechnology include bioreactors, fermenters, incubators, centrifuges, and chromatography systems. Bioreactors are engineered systems that provide a controlled environment for the growth of cells, tissues, or microorganisms, optimizing biological processes, enhancing productivity, and supporting both research and industrial-scale applications. Relevant technologies include CRISPR tools, next-generation sequencing, and polymerase chain reaction (PCR) technology. Applications span genetic engineering, plant tissue culture, molecular farming, biopesticides, and biofertilizers, serving end users such as agriculture, research institutions, biotechnology companies, pharmaceutical firms, and the food and beverage industry.

The countries covered in the plant biotechnology equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plant biotechnology equipment market consists of revenues earned by entities by providing services such as tissue culture propagation, genetic engineering support, plant transformation and regeneration, micropropagation, cryopreservation, and molecular analysis of plant cells and tissues. The market value includes the value of related goods sold by the service provider or included within the service offering. The plant biotechnology equipment market also includes sales of gene sequencers, polymerase chain reaction systems, electrophoresis equipment, microarray systems, and plant tissue culture chambers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.